2023-05-122023-05-122023Kartti, S., Bendani, H., Boumajdi, N., Bouricha, E.M., Zarrik, O., EL, Agouri, H., Fokar, M., Aghlallou, Y., EL, Jaoudi, R., Belyamani, L., Elkhannoussi, B., & Ibrahimi, A.. 2023. Metagenomics Analysis of Breast Microbiome Highlights the Abundance of Rothia Genus in Tumor Tissues. Journal of Personalized Medicine, 13(3). https://doi.org/10.3390/jpm13030450https://doi.org/10.3390/jpm13030450https://hdl.handle.net/2346/93538© 2023 by the authors. cc-byBreast cancer is one of the main global priorities in terms of public health. It remains the most frequent cancer in women and is the leading cause of their death. The human microbiome plays various roles in maintaining health by ensuring a dynamic balance with the host or in the appearance of various pathologies including breast cancer. In this study, we performed an analysis of bacterial signature differences between tumor and adjacent tissues of breast cancer patients in Morocco. Using 16S rRNA gene sequencing, we observed that adjacent tissue contained a much higher percentage of the Gammaproteobacteria class (35.7%) while tumor tissue was characterized by a higher percentage of Bacilli and Actinobacteria classes, with about 18.8% and 17.2% average abundance, respectively. Analysis of tumor subtype revealed enrichment of genus Sphingomonodas in TNBC while Sphingomonodas was predominant in HER2. The LEfSe and the genus level heatmap analysis revealed a higher abundance of the Rothia genus in tumor tissues. The identified microbial communities can therefore serve as potential biomarkers for prognosis and diagnosis, while also helping to develop new strategies for the treatment of breast cancer patients.eng16s rRNA sequencingbreast cancermetagenomicsmicrobiomerhotiaArticle